-
1
-
-
84940554623
-
-
Updated June 25
-
Regulatory Affairs Professionals Society: 'Right-to-Try' Legislation Tracker. Updated June 25, 2015. www.raps.org/Regulatory-Focus/News/Databases/2015/05/01/21133/Right-to-Try-Legislation-Tracker/
-
(2015)
'Right-to-Try' Legislation Tracker
-
-
-
2
-
-
84902487175
-
Live or let die: Will the courts recognize in terminally ill patients a fundamental right to choose non-FDA approved drugs or does the FDA's stringent approval process carry sufficient merit?
-
Clayton RP: Live or let die: Will the courts recognize in terminally ill patients a fundamental right to choose non-FDA approved drugs or does the FDA's stringent approval process carry sufficient merit? Indiana Health Law Rev 5:123-153, 2008
-
(2008)
Indiana Health Law Rev
, vol.5
, pp. 123-153
-
-
Clayton, R.P.1
-
3
-
-
84940536716
-
-
Updated April 9
-
Health Affairs: Health Policy Brief: Right-to-Try Laws. Updated April 9, 2015. http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief-id=135
-
(2015)
Health Policy Brief: Right-to-Try Laws
-
-
-
5
-
-
84940551816
-
-
U.S. Constitution, Article VI, Clause 2
-
U.S. Constitution, Article VI, Clause 2
-
-
-
-
6
-
-
70149104075
-
Expanded access to investigational drugs for treatment use. Final rule
-
US Food and Drug Administration, Health and Human Services: Expanded access to investigational drugs for treatment use. Final rule. Fed Regist 74:40900-40945, 2009
-
(2009)
Fed Regist
, vol.74
, pp. 40900-40945
-
-
US Food and Drug Administration1
Health and Human Services2
-
7
-
-
84920999925
-
Access to investigational drugs remains challenge despite new FDA rules
-
March 29
-
Hayes E: Access to investigational drugs remains challenge despite new FDA rules. Pink Sheet. Volume 31, March 29, 2010
-
(2010)
Pink Sheet
, vol.31
-
-
Hayes, E.1
-
8
-
-
70349928587
-
Expanded access rules pose quandary for drug developers
-
Mack GS: Expanded access rules pose quandary for drug developers. Nat Biotechnol 27:871-872, 2009
-
(2009)
Nat Biotechnol
, vol.27
, pp. 871-872
-
-
Mack, G.S.1
-
9
-
-
84940512933
-
False hope and toxic effects: Proposed changes to the FDA drug approval process would fail to benefit the terminally ill
-
Zacher A: False hope and toxic effects: Proposed changes to the FDA drug approval process would fail to benefit the terminally ill. Quinnipiac Health Law 14:251-283, 2011
-
(2011)
Quinnipiac Health Law
, vol.14
, pp. 251-283
-
-
Zacher, A.1
-
10
-
-
84920973014
-
Practical, legal, and ethical issues in expanded access to investigational drugs
-
Darrow JJ, Sarpatwari A, Avorn J, et al: Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med 372:279-286, 2015
-
(2015)
N Engl J Med
, vol.372
, pp. 279-286
-
-
Darrow, J.J.1
Sarpatwari, A.2
Avorn, J.3
-
11
-
-
80053352042
-
Translational research: 4 Ways to fix the clinical trial
-
Ledford H: Translational research: 4 ways to fix the clinical trial. Nature 477:526-528, 2011
-
(2011)
Nature
, vol.477
, pp. 526-528
-
-
Ledford, H.1
-
12
-
-
84929906921
-
Principles and challenges in access to experimental medicines
-
Rosenblatt M, Kuhlik B: Principles and challenges in access to experimental medicines. JAMA 313:2023-2024, 2015
-
(2015)
JAMA
, vol.313
, pp. 2023-2024
-
-
Rosenblatt, M.1
Kuhlik, B.2
|